Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Cipla
Merck
Cerilliant
Deloitte
Baxter
Johnson and Johnson
Fuji
Teva

Generated: January 18, 2018

DrugPatentWatch Database Preview

CECLOR Drug Profile

« Back to Dashboard

When do Ceclor patents expire, and what generic alternatives are available?

Ceclor is a drug marketed by Lilly and is included in three NDAs.

The generic ingredient in CECLOR is cefaclor. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
Drug patent expirations by year for CECLOR
Medical Subject Heading (MeSH) Categories for CECLOR

US Patents and Regulatory Information for CECLOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly CECLOR cefaclor CAPSULE;ORAL 050521-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly CECLOR cefaclor FOR SUSPENSION;ORAL 050522-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly CECLOR cefaclor CAPSULE;ORAL 050521-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly CECLOR cefaclor FOR SUSPENSION;ORAL 050522-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly CECLOR CD cefaclor TABLET, EXTENDED RELEASE;ORAL 050673-002 Jun 28, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly CECLOR CD cefaclor TABLET, EXTENDED RELEASE;ORAL 050673-001 Jun 28, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Mallinckrodt
Daiichi Sankyo
Baxter
Merck
Boehringer Ingelheim
Chubb
Cipla
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot